← All trials
NCT05665140
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2023
- Primary completion
- Aug 31, 2027
- Completion date
- Oct 31, 2028
- First posted
- Dec 26, 2022
- Last posted
- Dec 26, 2022
- Enrollment
- 100
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Universitaetsklinikum Schleswig-HolsteinLead sponsor
- Universitaetsklinikum Schleswig-HolsteinReponsible party - principal investigator
- Universitaetsklinikum Schleswig-HolsteinSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.